ACTIVITIES OF LL-37, A CATHELIN-ASSOCIATED ANTIMICROBIAL PEPTIDE OF HUMAN NEUTROPHILS

Citation
J. Turner et al., ACTIVITIES OF LL-37, A CATHELIN-ASSOCIATED ANTIMICROBIAL PEPTIDE OF HUMAN NEUTROPHILS, Antimicrobial agents and chemotherapy, 42(9), 1998, pp. 2206-2214
Citations number
53
Categorie Soggetti
Pharmacology & Pharmacy",Microbiology
ISSN journal
00664804
Volume
42
Issue
9
Year of publication
1998
Pages
2206 - 2214
Database
ISI
SICI code
0066-4804(1998)42:9<2206:AOLACA>2.0.ZU;2-M
Abstract
Human neutrophils contain two structurally distinct types of antimicro bial peptides, P-sheet defensins (HNP-1 to HNP-4) and the alpha-helica l peptide LL-37, We used radial diffusion assays and an improved Natio nal Committee for Clinical Laboratory Standards-type broth microdiluti on assay to compare the antimicrobial properties of LL-37, HNP-1, and protegrin (PG-1), Although generally less potent than PC-1, LL-37 show ed considerable activity (MIC, <10 mu g/ml) against Pseudomonas aerugi nosa, Salmonella typhimurium, Escherichia coli, Listeria monocytogenes , Staphylococcus epidermidis, Staphylococcus aureus, and vancomycin-re sistant enterococci, even in media that contained 100 mM NaCl, Certain organisms (methicillin resistant S, aureus, Proteus mirabilis, and Ca ndida albicans) were resistant to LL-37 in media that contained 100 mM NaCl but were susceptible in low-salt media. Burkholderia cepacia was resistant to LL-37, PC-1, and HNP-1 in low- or high-salt media. LL-37 caused outer and inner membrane permeabilization of E. coli ML-35p. C hromogenic Limulus assays revealed that LL-37 bound to E, coli O111:B4 lipopolysaccharide (LPS) with a high affinity and that this binding s howed positive cooperativity (Hill coefficient = 2.02), Circular dichr oism spectrometry disclosed that LL-37 underwent conformational change in the presence of lipid A, transitioning from a random coil to an al pha-helical structure, The broad-spectrum antimicrobial properties of LL-37, its presence in neutrophils, and its inducibility in keratinocy tes all suggest that this peptide and its precursor (hCAP-18) may prot ect skin and other tissues from bacterial intrusions and LPS-induced t oxicity. The potent activity of LL-37 against P. aeruginosa, including mucoid and antibiotic-resistant strains, suggests that it or related molecules might have utility as topical bronchopulmonary microbicides in cystic fibrosis.